收藏商品
全国免费服务热线
4000-520-616
PotentandselectivePDE8B/8Ainhibitor(IC50valuesare1.3and1.9nM,respectively).ExhibitsselectivityforPDE8A/BoverotherPDEs(IC50valuesare>10μM)andarangeofothertargets.Increasesglucose-dependentinsulinsecretionfromhumanpacreaticisletcells.Orallybioavailable.
SoldforresearchpurposesunderagreementfromPfizerInc
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight382.87.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
DeNinnoetal(2012)Discoveryoftriazolopyrimidine-basedPDE8Binhibitors:exceptionallyligand-efficientandlipophilicligand-efficientcompoundsforthetreatmentofdiabetes.Bioorg.Med.Chem.Lett.225721PMID:22858141
Keywords:PF04671536hydrochloride,supplier,PF04671536,hydrochloride,diabetes,phosphodiesterase,8A,8B,PDE,potent,selective,orally,bioavailable,antidiabetics,inhibitors,inhibits,Phosphodiesterases,Phosphodiesterases,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10